Airborne and surface contamination after rotational intraperitoneal pressurized aerosol chemotherapy using cisplatin.

During the RIPAC procedures, there is a potential risk of dermal exposure, as platinum, a surrogate material for cisplatin, was detected at low concentration levels in some surface samples. However, the respiratory exposure risk was not identified, as platinum was not detected in the airborne samples in this study.